T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$4.95B |
| 2 |
Broadcom
AVGO
|
+$3.48B |
| 3 |
Microsoft
MSFT
|
+$2.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.92B |
| 5 |
GE Aerospace
GE
|
+$1.49B |
Top Sells
| 1 |
Amazon
AMZN
|
+$3.79B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.63B |
| 3 |
Apple
AAPL
|
+$2.46B |
| 4 |
Fiserv
FI
|
+$2.19B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| 1 | Technology | 34.76% |
| 2 | Financials | 12.08% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Monte Rosa Therapeutics
GLUE
$302M
| $28.5M | ﹤0.01% |
6,325,658
-318,478
| -5% | -$1.44M |
|
877
Legend Biotech
LEGN
$6.24B
| $28.4M | ﹤0.01% |
800,220
-5,929,559
| -88% | -$210M |
|
878
SLM Corp
SLM
$6.05B
| $28.4M | ﹤0.01% |
865,031
+45,725
| +6% | +$1.5M |
|
879
Murphy USA
MUSA
$7.59B
| $28.3M | ﹤0.01% |
69,465
-124,536
| -64% | -$50.7M |
|
880
Hims & Hers Health
HIMS
$11.7B
| $28.1M | ﹤0.01% |
563,877
-84,895
| -13% | -$4.23M |
|
881
Oric Pharmaceuticals
ORIC
$1.05B
| $28M | ﹤0.01% |
2,762,915
+1,430,055
| +107% | +$14.5M |
|
882
Immunome
IMNM
$843M
| $27.7M | ﹤0.01% |
2,982,080
-87,527
| -3% | -$814K |
|
883
International Flavors & Fragrances
IFF
$17B
| $27.7M | ﹤0.01% |
376,082
-900,100
| -71% | -$66.2M |
|
884
Service Corp International
SCI
$11.3B
| $27.7M | ﹤0.01% |
339,658
-45,970
| -12% | -$3.74M |
|
885
Estee Lauder
EL
$31.2B
| $27.5M | ﹤0.01% |
340,661
-440,680
| -56% | -$35.6M |
|
886
Core & Main
CNM
$9.43B
| $27.5M | ﹤0.01% |
456,016
+32,370
| +8% | +$1.95M |
|
887
Trimble
TRMB
$19.7B
| $27.4M | ﹤0.01% |
361,135
-1,196
| -0.3% | -$90.9K |
|
888
Dow Inc
DOW
$17.7B
| $27.1M | ﹤0.01% |
1,024,927
+4,404
| +0.4% | +$117K |
|
889
Haemonetics
HAE
$2.58B
| $27M | ﹤0.01% |
361,442
+4,260
| +1% | +$318K |
|
890
Invitation Homes
INVH
$18.8B
| $26.9M | ﹤0.01% |
819,529
-5,527
| -0.7% | -$181K |
|
891
Addus HomeCare
ADUS
$2.07B
| $26.4M | ﹤0.01% |
229,265
+2,207
| +1% | +$254K |
|
892
Tapestry
TPR
$22.2B
| $26.3M | ﹤0.01% |
299,185
-116,034
| -28% | -$10.2M |
|
893
West Pharmaceutical
WST
$19B
| $25.7M | ﹤0.01% |
117,629
-37,122
| -24% | -$8.12M |
|
894
Vital Farms
VITL
$2.17B
| $25.6M | ﹤0.01% |
665,530
+3,472
| +0.5% | +$134K |
|
895
Braze
BRZE
$3.44B
| $25.5M | ﹤0.01% |
906,830
-172,906
| -16% | -$4.86M |
|
896
Stifel
SF
$11.8B
| $25.4M | ﹤0.01% |
244,909
-153,724
| -39% | -$16M |
|
897
Travel + Leisure Co
TNL
$4.11B
| $25.4M | ﹤0.01% |
491,903
+9,668
| +2% | +$499K |
|
898
Halliburton
HAL
$19B
| $25.3M | ﹤0.01% |
1,241,395
-231,417
| -16% | -$4.72M |
|
899
Mid-America Apartment Communities
MAA
$16.9B
| $25.2M | ﹤0.01% |
170,330
+1,551
| +0.9% | +$230K |
|
900
CACI
CACI
$10.8B
| $25.2M | ﹤0.01% |
52,832
+107
| +0.2% | +$51K |
|